The Safety and Effectiveness of the VaricElla zosteR VaccinE (VERVE) in Anti-TNF Users Trial
Latest Information Update: 25 Nov 2021
At a glance
- Drugs Varicella zoster virus vaccine live (Primary)
- Indications Herpes zoster
- Focus Pharmacodynamics
- Acronyms VERVE
- 28 Sep 2021 Results assessing safety and immunogenicity of the live attenuated zoster vaccine (ZVL) in patients receiving tumor necrosis factor inhibitors (TNFis), published in the Annals of Internal Medicine
- 25 Aug 2021 Status changed from active, no longer recruiting to completed.
- 25 Aug 2021 Results presented at the 37th International Conference on Pharmacoepidemiology and Therapeutic Risk Management